We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TH icon
1076
Target Hospitality
TH
$1.6B
$5.92M 0.01%
390,702
+101,639
+35% +$1.37M
CF icon
1077
CALL
CF Industries
CF
$18.4B
$5.9M 0.01%
+69,300
New +$7.04M
HWEL
1078
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$5.88M 0.01%
592,874
-3,338
-0.6% -$32.8K
NKGN
1079
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$5.87M 0.01%
589,724
GILD icon
1080
CALL
Gilead Sciences
GILD
$162B
$5.86M 0.01%
68,300
+5,400
+9% +$428K
AMODW
1081
CALL
Alpha Modus Holdings Warrant
AMODW
$256K
$5.85M 0.01%
579,883
HCP
1082
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$5.84M 0.01%
213,746
+139,726
+189% +$3.95M
LFAC
1083
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$5.84M 0.01%
569,515
CLAR icon
1084
Clarus
CLAR
$126M
$5.84M 0.01%
745,083
+543,765
+270% +$5.3M
HERAW
1085
CALL
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$5.83M 0.01%
575,994
PEGA icon
1086
Pegasystems
PEGA
$4.7B
$5.81M 0.01%
339,632
+98,242
+41% +$1.7M
ITAQ
1087
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
$5.81M 0.01%
571,143
DSAQ.WS
1088
CALL
DELISTED
Direct Selling Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DSAQ.WS
$5.81M 0.01%
564,755
MTVC.WS
1089
CALL
DELISTED
Motive Capital Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
MTVC.WS
$5.81M 0.01%
567,819
BIOTW
1090
CALL
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$5.81M 0.01%
575,000
DIS icon
1091
CALL
Walt Disney
DIS
$168B
$5.79M 0.01%
66,600
+66,200
+16,550% +$6.33M
DH icon
1092
Definitive Healthcare
DH
$71.1M
$5.77M 0.01%
525,463
+421,116
+404% +$5.41M
VYX icon
1093
NCR Voyix
VYX
$1.13B
$5.76M 0.01%
401,187
-124,677
-24% -$1.66M
FMIV
1094
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$5.75M 0.01%
572,366
-1,018,617
-64% -$10.1M
AQUA
1095
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$5.73M 0.01%
144,804
-101,332
-41% -$3.99M
PAYOW
1096
CALL
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$5.73M 0.01%
1,048,028
LZB icon
1097
La-Z-Boy
LZB
$1.62B
$5.72M 0.01%
250,557
+25,607
+11% +$623K
ED icon
1098
Consolidated Edison
ED
$41.1B
$5.71M 0.01%
59,956
-680,088
-92% -$61.9M
IBP icon
1099
Installed Building Products
IBP
$6.16B
$5.68M 0.01%
66,405
+63,405
+2,114% +$5.34M
LIBY
1100
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
$5.67M 0.01%
555,472

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.